Clinical Utility of Measuring Infliximab (IFX) and...

Clinical Utility of Measuring Infliximab (IFX) and Adalimumab (ADA) and Anti-drug Antibody Levels Using the LabCorp Assay in Patients With Inflammatory Bowel Disease (IBD)

Brown, Sara, Perinbasekar, Rajiv, Syed, Nauroz, Lonsako, Shumet, Cross, Raymond
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
112
Journal:
American Journal of Gastroenterology
DOI:
10.14309/00000434-201710001-00735
Date:
October, 2017
File:
PDF, 115 KB
2017
Conversion to is in progress
Conversion to is failed